Opioid-exposed newborns deserve more. Now there’s an FDA-authorized device to treat them, and the evidence to back it up.

April 23, 2026

Author: John Konsin, Principal Founder, Prapela, Inc. | April 23, 2026 Prapela is pleased to make our Clinical Evidence Summary available to clinicians, NICU leaders, and care teams managing NAS/NOWS. This peer-reviewed resource covers: ✅ The pivotal study, Bloch-Salisbury et al. RCT (JAMA Pediatrics, 2023, n=181).✅ The Singh et al. multicenter RCT (Pediatric Research, 2025)…
Read more